Related Experiment Video

Updated: Apr 7, 2026

A Protocol for Rapid Post-mortem Cell Culture of Diffuse Intrinsic Pontine Glioma DIPG
08:46

A Protocol for Rapid Post-mortem Cell Culture of Diffuse Intrinsic Pontine Glioma DIPG

Published on: March 7, 2017

17.7K

Functionally defined therapeutic targets in diffuse intrinsic pontine glioma

Catherine S Grasso, Yujie Tang, Nathalene Truffaux

    Nature Medicine
    |July 8, 2015
    PubMed
    Summary

    No abstract available in PubMed .

    More Related Videos

    Digital Spatial Profiling for Characterization of the Microenvironment in Adult-Type Diffusely Infiltrating Glioma
    09:17

    Digital Spatial Profiling for Characterization of the Microenvironment in Adult-Type Diffusely Infiltrating Glioma

    Published on: September 13, 2022

    2.8K
    Establishment of Orthotopic Patient-derived Xenograft Models for Brain Tumors using a Stereotaxic Device
    07:44

    Establishment of Orthotopic Patient-derived Xenograft Models for Brain Tumors using a Stereotaxic Device

    Published on: May 2, 2025

    1.1K

    Related Experiment Videos

    Last Updated: Apr 7, 2026

    A Protocol for Rapid Post-mortem Cell Culture of Diffuse Intrinsic Pontine Glioma DIPG
    08:46

    A Protocol for Rapid Post-mortem Cell Culture of Diffuse Intrinsic Pontine Glioma DIPG

    Published on: March 7, 2017

    17.7K
    Digital Spatial Profiling for Characterization of the Microenvironment in Adult-Type Diffusely Infiltrating Glioma
    09:17

    Digital Spatial Profiling for Characterization of the Microenvironment in Adult-Type Diffusely Infiltrating Glioma

    Published on: September 13, 2022

    2.8K
    Establishment of Orthotopic Patient-derived Xenograft Models for Brain Tumors using a Stereotaxic Device
    07:44

    Establishment of Orthotopic Patient-derived Xenograft Models for Brain Tumors using a Stereotaxic Device

    Published on: May 2, 2025

    1.1K

    Related Concept Videos

    Targeted Cancer Therapies02:57

    Targeted Cancer Therapies

    9.1K
    The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
    There are several types of targeted therapies against...
    9.1K

    Articles linked to this work by shared authors, journal, and citation graph.

    Paediatric Therapeutic Development Workshop on rhabdomyosarcoma.

    British journal of cancer·2026

    System for study of diverse cellular composition in alveolar rhabdomyosarcoma.

    Scientific reports·2026

    Development of an Active Chimeric IL13Rα2 ADC for Diffuse Intrinsic Pontine Glioma.

    ImmunoTargets and therapy·2026

    Genomic Landscape of Myoepithelial Carcinoma Tumors.

    Oral diseases·2026

    Disrupting resistance: novel therapeutic approaches to combat multidrug resistance in fusion-negative rhabdomyosarcoma.

    Cancer drug resistance (Alhambra, Calif.)·2025

    Development of cell lines with increased susceptibility to diverse adeno-associated viral vectors to enable in vitro potency assays.

    Molecular therapy. Methods & clinical development·2025

    Decade-long persistence of CD19 CAR T cells in B cell lymphomas.

    Nature medicine·2026

    Obinutuzumab β for aquaporin-4-positive neuromyelitis optica spectrum disorder: a phase 3 randomized controlled trial.

    Nature medicine·2026

    Type 2 diabetes prevention across the life course.

    Nature medicine·2026

    Large-scale whole-genome sequencing reveals the landscape and health implications of de novo mutations.

    Nature medicine·2026

    A clinically validated framework for auditing AI chatbot behavior in mental health interactions.

    Nature medicine·2026

    Intracranial delivery of B7-H3-targeting CAR-T cells for recurrent glioblastoma: a phase 1 trial.

    Nature medicine·2026
    See all related articles
    JoVE
    x logofacebook logolinkedin logoyoutube logo
    ABOUT JoVE
    OverviewLeadershipBlogJoVE Help Center
    AUTHORS
    Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
    LIBRARIANS
    TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
    RESEARCH
    JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
    EDUCATION
    JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
    Terms & Conditions of Use
    Privacy Policy
    Policies
    Jove
    Visualize
    Contact Us